ATI RN
ATI RN Pharmacology 2023 Retake 2 Questions
Extract:
Question 1 of 5
A nurse is assessing a client who is taking warfarin. Which of the following findings should the nurse identify as the priority to report to the provider?
Correct Answer: B
Rationale: The correct answer is B: Melena. Melena is a sign of gastrointestinal bleeding, which can be a serious complication of warfarin therapy due to its anticoagulant effects. Reporting melena promptly is crucial to prevent further complications like hemorrhage. Hair loss (
A) is a common side effect of warfarin but not a priority compared to potential bleeding. Abdominal cramping (
C) can occur but does not indicate immediate danger. Fever (
D) is not directly related to warfarin therapy and may be due to other causes.
Question 2 of 5
A nurse is teaching a client who has a new prescription for total parenteral nutrition (TPN). Which of the following information should the nurse include in the teaching?
Correct Answer: C
Rationale: The correct answer is C. TPN provides nutrients while giving the bowels time to rest. This is important because TPN bypasses the digestive system, allowing the bowels to rest and heal.
Choice A is incorrect as TPN does not stimulate appetite.
Choice B is incorrect as TPN is not primarily for medication absorption.
Choice D is incorrect as TPN is not used to keep bowels clear for surgery.
Question 3 of 5
A nurse is planning care for a group of clients. Which of the following client's medications should be monitored by the nurse for hearing loss related to a medication interaction?
Correct Answer: D
Rationale: The correct answer is D: Furosemide and amikacin. Furosemide and aminoglycosides like amikacin can cause ototoxicity, leading to hearing loss. Furosemide can enhance the ototoxic effects of aminoglycosides. Monitoring for hearing loss is crucial when these medications are used together.
Choice A (Digoxin and levothyroxine) is incorrect as these medications are not known to cause hearing loss.
Choice B (Losartan and atorvastatin) is incorrect as these medications do not commonly cause hearing loss.
Choice C (Propranolol and raloxifene) is incorrect as these medications are not associated with hearing loss.
Question 4 of 5
A nurse is caring for a client who has a gonococcal infection and has been prescribed an IM injection of ceftriaxone. The client refuses the medication because they are afraid of needles. Which of the following responses should the nurse make?
Correct Answer: D
Rationale: The correct response is D: I will discuss other treatment options with your provider. This is the best choice because it shows empathy towards the client's fear of needles and acknowledges their concerns. The nurse is committed to finding an alternative treatment that the client is comfortable with, ensuring the client receives the necessary care while respecting their autonomy. This response promotes a collaborative approach to care and maintains a therapeutic nurse-client relationship.
Other choices are incorrect:
A: This response minimizes the client's fear but does not address the underlying issue of the client's refusal.
B: This response is coercive and does not consider the client's feelings, which can lead to non-compliance.
C: This response is threatening and may cause the client to feel guilt or fear, which is not conducive to effective communication.
E, F, G: These choices are not relevant to the situation and do not address the client's specific concerns.
Question 5 of 5
A nurse is preparing to administer a scheduled dose of warfarin to a client. Which of the following laboratory tests should the nurse review prior to administration?
Correct Answer: B
Rationale: The correct answer is B: PT. The nurse should review the PT (Prothrombin Time) test before administering warfarin because warfarin is an anticoagulant medication that works by inhibiting the clotting factors dependent on vitamin K, including factor II (prothrombin). Monitoring the PT helps ensure that the client's blood is clotting appropriately, as warfarin therapy requires a specific target range for PT known as the INR (International Normalized Ratio). Reviewing the PT will help the nurse assess the client's clotting status and adjust the warfarin dosage accordingly.
Choice A, PTT (Partial Thromboplastin Time), is not specific to monitoring warfarin therapy; it is more commonly used to assess the intrinsic pathway of coagulation.
Choice C, WBC (White Blood Cell count), and choice D,
Total Iron-Binding Capacity, are not relevant to monitoring warfarin therapy and are unrelated to clotting function